Earnings
Genovis became certified to ISO 9001:2015 Quality certification means that the management system meets the requirements imposed by International Standard ISO 9001:2015. The certification covers product development, production and sales.
Fusion Antibodies plc announces its unaudited interim results for the six months ended 30 September 2018.
Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic
Four ongoing clinical trial programs
Positive outcomes from second Phase 1 trial with intranasal betahistine
SUVEN LIFE Sciences Limited, a biopharmaceutical company specializing in drug discovery and developmental activities in Central Nervous System disorders, today announced its Un-audited financial results for the quarter ended 30th September 2018. The un-audited financial results were reviewed by the audit committee and approved by the Board of Directors in their meeting held on 14th Nov’ 2018 at Hyderabad.
BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients. AbbVie exercises its option to a license for Parkinson’s projects
Medigene AG today reported financial results for the first 9 months of 2018 and provided a review of recent accomplishments and anticipated upcoming milestones.
Company to host conference call today at 8:30am ET
GeoVax Labs, Inc. announced its financial results for the quarter ended September 30, 2018, and provided an update on its research and development programs.
PRESS RELEASES